Alabama Hospital Bacterial Infections Linked to Contaminated IV Bags

Federal drug regulators indicate that unsanitary conditions at a specialty pharmacy in Alabama led to a bacterial outbreak in several local hospitals, which may have contributed to the death of at least nine people. 

The FDA sent a warning letter to Advanced Specialty Pharmacy, an Alabama pharmacy that was doing business as Meds IV last year when its Total Parentaral Nutrition IV bags were linked to a deadly bacterial outbreak. The letter indicates that the FDA believes that the recalled IV drugs were prepared, packed or held in unsanitary conditions and may have been “contaminated with filth.”

The fact that the drugs were contaminated and sold to the public means they were misbranded as safe, according to the FDA’s letter. Bacteria identical to that which killed and sickened patients was found on faucets inside the production facility.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

In March 2011, Meds IV, an Alabama compounding pharmacy shut their doors and issued a recall for IV bags that contained a liquid nutrient known as Total Parenteral Nutrition (TPN). 

The  recall was issued after an outbreak of infections involving Serratia marcescens bacteria were identified at six different Alabama hospitals where the IV bags were used. Several hospital infection lawsuits were filed as a result.

The Alabama hospitals known to have received the tainted IV bags include Baptist Princeton, Baptist Shelby, Baptist Prattville, Medical West, Cooper Green Mercy and Select Specialty Hospital in Birmingham.

The FDA acknowledges that the company has surrendered its pharmacy license as a result of the incident. If the company were ever attempt to reopen, it would have to tell the FDA at least 15 days ahead of time, explaining how it would prevent a similar outbreak.

Serratia marcescens is a waterborne bacteria that can cause fever, respiratory problems and shock.  The Alabama Department of Public Health investigators found bacteria on a faucet and medical equipment at the Meds IV lab.  The company has since decided to cease operations and officials with the Centers for Disease Control and Prevention (CDC) have indicated that it is unlikely the business will reopen.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

EU Launches Investigation Into Ozempic Vision Loss Problems
EU Launches Investigation Into Ozempic Vision Loss Problems (Posted 3 days ago)

Following nearly 20 reports of vision problems from Ozempic or Wegovy since a study was published in July 2024, Danish health officials are calling for an EU investigation into the safety of semaglutide-based drugs.